首页> 外文期刊>The Journal of Physiology >Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations
【24h】

Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations

机译:挽救蛋白质表达缺陷可能不足以消除长QT 2型突变的心律失常表型

获取原文
获取原文并翻译 | 示例
           

摘要

In the heart, Kv11.1 channels pass the rapid delayed rectifier current (I-Kr) which plays critical roles in repolarization of the cardiac action potential and in the suppression of arrhythmias caused by premature stimuli. Over 500 inherited mutations in Kv11.1 are known to cause long QT syndrome type 2 (LQTS2), a cardiac electrical disorder associated with an increased risk of life threatening arrhythmias. Most missense mutations in Kv11.1 reduce the amount of channel protein expressed at the membrane and, as a consequence, there has been considerable interest in developing pharmacological agents to rescue the expression of these channels. However, pharmacological chaperones will only have clinical utility if the mutant Kv11.1 channels function normally after membrane expression is restored. The aim of this study was to characterize the gating phenotype for a subset of LQTS2 mutations to assess what proportion of mutations may be suitable for rescue. As an initial screen we used reduced temperature to rescue expression defects of mutant channels expressed in Xenopus laevis oocytes. Over half (similar to 56%) of Kv11.1 mutants exhibited functional gating defects that either dramatically reduced the amount of current contributing to cardiac action potential repolarization and/or reduced the amount of protective current elicited in response to premature depolarizations. Our data demonstrate that if pharmacological rescue of protein expression defects is going to have clinical utility in the treatment of LQTS2 then it will be important to assess the gating phenotype of LQTS2 mutations before attempting rescue.
机译:在心脏中,Kv11.1通道通过快速延迟的整流器电流(I-Kr),该电流在心脏动作电位的复极化和抑制过早刺激引起的心律失常中起关键作用。已知Kv11.1中超过500个遗传突变会导致2型长QT综合征(LQTS2),这是一种心脏电疾病,与威胁生命的心律失常的风险增加有关。 Kv11.1中的大多数错义突变都会减少在膜上表达的通道蛋白的数量,因此,人们对开发可挽救这些通道表达的药理学药物引起了极大的兴趣。但是,仅当突变的Kv11.1通道在膜表达恢复后正常运行时,药理伴侣分子才具有临床用途。这项研究的目的是表征LQTS2突变子集的门控表型,以评估何种比例的突变可能适合抢救。作为初始筛选,我们使用降低的温度来挽救非洲爪蟾卵母细胞中表达的突变通道的表达缺陷。超过一半(约56%)的Kv11.1突变体表现出功能门控缺陷,这些缺陷显着减少了有助于心脏动作电位复极的电流量和/或减少了响应于过早去极化而引起的保护性电流量。我们的数据表明,如果蛋白表达缺陷的药理学挽救在LQTS2的治疗中具有临床应用,那么在尝试挽救LQTS2突变的门控表型时将很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号